Waverly Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$513K Sell
10,640
-2,025
-16% -$94.4K ﹤0.01% 1075
2025
Q4
$614K Buy
12,665
+2,654
+27% +$132K 0.01% 925
2025
Q3
$473K Sell
10,011
-9
-0.1% -$434 ﹤0.01% 864
2025
Q2
$484K Buy
10,020
+174
+2% +$8.89K 0.01% 812
2025
Q1
$546K Buy
9,846
+56
+0.6% +$3.03K 0.01% 749
2024
Q4
$472K Buy
9,790
+4,082
+72% +$208K 0.01% 698
2024
Q3
$329K Hold
5,708
0.01% 663
2024
Q2
$277K Buy
5,708
+906
+19% +$43.7K 0.01% 687
2024
Q1
$233K Buy
+4,802
New +$234K 0.01% 621
2015
Q4
Sell
-83
Closed -$4K 352
2015
Q3
$4K Hold
83
﹤0.01% 391
2015
Q2
$4K Buy
+83
New +$4.21K ﹤0.01% 323
2014
Q4
Sell
-331
Closed -$19K 635
2014
Q3
$19K Hold
331
0.01% 350
2014
Q2
$18K Hold
331
0.01% 351
2014
Q1
$17K Sell
331
-449
-58% -$22.7K 0.01% 347
2013
Q4
$42K Buy
780
+331
+74% +$17.1K 0.01% 355
2013
Q3
$23K Buy
+449
New +$22.8K 0.01% 341

Other funds holding SNY

Waverly Advisors's SNY Position: Q1 2026 in Review

Waverly Advisors reduced its Sanofi (SNY) stake by 16% in Q1 2026, selling an estimated $94.4K and leaving 10,640 shares worth $513K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Waverly Advisors first reported a position in SNY in Q3 2013 and has held it in 16 quarters since. The position peaked at $614K in Q4 2025. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Waverly Advisors held 10,640 shares of Sanofi worth $513K as of Q1 2026.
  • Waverly Advisors sold 2,025 Sanofi shares in Q1 2026, an estimated $94.4K.
  • Sanofi made up ﹤0.01% of Waverly Advisors's portfolio in Q1 2026, its #1075 holding.
  • Waverly Advisors first reported a position in Sanofi in Q3 2013 and has held it in 16 quarters since.
  • Waverly Advisors's Sanofi position peaked at $614K in Q4 2025.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Waverly Advisors's 13F filing for Q1 2026, filed 15 May 2026.